Jefferies Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Jefferies Group’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-78,800	Closed	-$4.13M	–	1940
2020 Q3	$4.13M	Buy	+78,800	New	+$3.26M	0.05%	334
2014 Q3	–	Sell	-98,500	Closed	-$1.19M	–	2563
2014 Q2	$1.19M	Buy	98,500 +78,500	+393%	+$927K	0.01%	834
2014 Q1	$233K	Sell	20,000 -9,500	-32%	-$161K	﹤0.01%	1652
2013 Q4	$522K	Buy	+29,500	New	+$496K	﹤0.01%	1134

Jefferies Group's MNTA Position: Q4 2017 in Review

Jefferies Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2017, closing a stake of 13,227 shares — an estimated $245K sold.

Jefferies Group first reported a position in MNTA in Q4 2013 and held it in 5 quarters. The position peaked at $834K in Q4 2013. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.

Jefferies Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Jefferies Group sold 13,227 Momenta Pharmaceuticals, Inc. shares in Q4 2017, an estimated $245K.
Jefferies Group first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
Jefferies Group's Momenta Pharmaceuticals, Inc. position peaked at $834K in Q4 2013.
166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2017.

Based on Jefferies Group's 13F filing for Q4 2017, filed 14 Feb 2018.